Literature DB >> 12767374

Total and free serum prostate specific antigen levels during the first month of acute prostatitis.

Xavier Gamé1, Sébastien Vincendeau, Robert Palascak, Stéphane Milcent, Robert Fournier, Alain Houlgatte.   

Abstract

OBJECTIVES: The level of total prostate specific antigen (PSA) rises in acute prostatitis. The PSA fraction responsible for this increase and the evolution of the free/total PSA ratio are little known at the present time. We therefore carried out a prospective study of the evolution of total and free PSA levels and the free-to-total PSA ratio for one month after diagnosis of acute prostatitis. PATIENTS AND METHODS: Between January 1999 and February 2001, 31 consecutive patients (mean age 51 years) were treated for acute prostatitis. No patient had a history of prostate cancer or of recent prostatitis. Measurement of C-reactive protein (CRP), total PSA and free PSA was done at days 0, 3, 10 and 30.
RESULTS: During the first month of acute prostatitis and under an adapted antibiotherapy, CRP progressively decreased and returned to normal levels at about day 10. Total PSA level increased up to day 3 and then gradually decreased until at least the end of the first month. The level of free PSA decreased up to day 10 and was still low at one month, leading to a decrease in the free-to-total PSA ratio which was reached its lowest level at day 10 and was still low at one month.
CONCLUSION: The increased level of total PSA in acute prostatitis is secondary to the proportional increase in bound serum PSA and decrease in free PSA. Free PSA was still low at one month, maintaining a low free-to-total PSA ratio.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767374     DOI: 10.1016/s0302-2838(03)00158-1

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

1.  Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.

Authors:  Melissa Milbrandt; Anke C Winter; Remington L Nevin; Ratna Pakpahan; Gary Bradwin; Angelo M De Marzo; Debra J Elliott; Charlotte A Gaydos; William B Isaacs; William G Nelson; Nader Rifai; Lori J Sokoll; Jonathan M Zenilman; Elizabeth A Platz; Siobhan Sutcliffe
Journal:  Prostate       Date:  2017-07-12       Impact factor: 4.104

2.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

Review 3.  The etiology and management of acute prostatitis.

Authors:  Christopher M Brede; Daniel A Shoskes
Journal:  Nat Rev Urol       Date:  2011-03-15       Impact factor: 14.432

Review 4.  Prostatitis and serum prostate-specific antigen.

Authors:  Puneet Sindhwani; Christopher M Wilson
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

5.  Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker.

Authors:  Xiaolong Qian; Changling Li; Bo Pang; Meng Xue; Jian Wang; Jianguang Zhou
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

6.  Impact of poor glycemic control of type 2 diabetes mellitus on serum prostate-specific antigen concentrations in men.

Authors:  Hasan Anıl Atalay; Murat Akarsu; Lutfi Canat; Volkan Ülker; İlter Alkan; Unsal Ozkuvancı
Journal:  Prostate Int       Date:  2017-03-03

7.  New Bacterial Infection in the Prostate after Transrectal Prostate Biopsy.

Authors:  Yumi Seo; Gilho Lee
Journal:  J Korean Med Sci       Date:  2018-04-06       Impact factor: 2.153

8.  Prostate-specific antigen, sexual behavior, and sexually transmitted infections in US men 40-59 years old, 2001-2004: a cross-sectional study.

Authors:  David M Werny; Mona Saraiya; Xiao Chen; Elizabeth A Platz
Journal:  Infect Agent Cancer       Date:  2007-10-24       Impact factor: 2.965

9.  Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis.

Authors:  Tijl Vermassen; Charles Van Praet; Filip Poelaert; Nicolaas Lumen; Karel Decaestecker; Piet Hoebeke; Simon Van Belle; Sylvie Rottey; Joris Delanghe
Journal:  Biochem Med (Zagreb)       Date:  2015-10-15       Impact factor: 2.313

Review 10.  Prostate cancer biology & genomics.

Authors:  Hayley Whitaker; Joseph O Tam; Martin J Connor; Alistair Grey
Journal:  Transl Androl Urol       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.